After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Recently, Yahoo Finance discussed the stock, revealing that 10x Genomics to Report First Quarter 2024 Financial Results on April 30, 2024.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
10x Genomics Inc is listed on the NASDAQ in the Healthcare sector while operating in the Health Information Services industry. The current market capitalization of 10x Genomics Inc is $4.33B. A total of 1.58 million shares were traded on the day, compared to an average of 1.37M shares.
In the most recent transaction, Saxonov Serge sold 4,660 shares of TXG for 44.00 per share on Mar 04 ’24. After the transaction, the Chief Executive Officer now owns 842,900 company shares. In a previous transaction on Feb 22 ’24, Saxonov Serge sold 2,821 shares at 46.34 per share. TXG shares that Chief Executive Officer owns now total 847,560.
Among the insiders who sold shares, Hindson Benjamin J. disposed of 2,613 shares on Feb 22 ’24 at a per-share price of $46.34. This resulted in the insider holding 283,059 shares of TXG after the transaction. In another insider transaction, McAnear Justin J. sold 1,865 shares at $46.34 per share on Feb 22 ’24. Company shares held by the Chief Financial Officer now total 95,240.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, TXG has a high of $63.57 and a low of $33.79.
As of this writing, TXG has an earnings estimate of -$0.5 per share for the current quarter. EPS was calculated based on a consensus of 15 estimates, with a high estimate of -$0.31 per share and a lower estimate of -$0.65. The company reported an EPS of -$0.79 in the last quarter, which was -71.70% lower than expectations of -$0.46.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. TXG’s latest balance sheet shows that the firm has $587.45M in Cash & Short Term Investments as of fiscal 2021. There were $81.98M in debt and $110.36M in liabilities at the time. Its Book Value Per Share was $6.22, while its Total Shareholder’s Equity was $817.57M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for TXG is Buy with a score of 4.31.
